Commercialization, • 9/19/25 Case Studies in Rare Disease Commercialization: Lessons Learned Previous Patient-Centric Commercialization: Integrating Patient Voices into Market Access Strategies You Might Also Like Closing Panel: Beyond “One Disease At a Time”: Platform Approaches to Accelerate Gene Therapy Trials Patient Recruitment and Engagement in in Global, Multisite Rare Disease Trials What Matters to Payers: Conversations You Should Start During Phase 2 Opening Keynote: The Evolving Regulatory Environment for Rare Disease Trials Leveraging Patient Advocacy To Scale Rare Disease Trials
Commercialization, • 9/19/25 Case Studies in Rare Disease Commercialization: Lessons Learned Previous Patient-Centric Commercialization: Integrating Patient Voices into Market Access Strategies You Might Also Like Closing Panel: Beyond “One Disease At a Time”: Platform Approaches to Accelerate Gene Therapy Trials Patient Recruitment and Engagement in in Global, Multisite Rare Disease Trials What Matters to Payers: Conversations You Should Start During Phase 2 Opening Keynote: The Evolving Regulatory Environment for Rare Disease Trials Leveraging Patient Advocacy To Scale Rare Disease Trials
